Abstract
The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) project was the largest and most extensive trial of antidepressants ever conducted. The study used state of- the-art methods to treat real patients coming to a hospital or psychiatric clinic for relief from depression. Because the first antidepressant is often ineffective for most patients, a sequence of drug treatments targeting various brain neurochemicals was carefully planned. This article will review the complex treatments and the various outcomes, including the frequency of relapse during twelve months of follow-up care.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fava, M., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., et al. (2006). A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: A STAR*D Report. The American Journal of Psychiatry, 163, 1161–1172.
Kirsch, I., Moore, T. J., Scobabria, A., & Nicholls, S. S. (2002). The emperor’s new drugs: An analysis of antidepressive medication data submitted to the U. S. food and drug administration. Prevention & Treatment, 5(23). http://content.apa.org/journals/pre/5/1/33.
McGrath, P. J., Stewart, J. W., Fava, M., Trivedi, M. H., et al. (2006). Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: A STAR*D Report. The American Journal of Psychiatry, 163, 1531–1541.
Nierenberg, A. A., Fava, M., Trivedi, M. D., Wisniewski, S. R., et al. (2006). A comparison of lithium and T3 augmentation following two failed medication treatments for depression: A STAR*D report. The American Journal of Psychiatry, 163, 1519–1530.
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., et al. (2004). Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design. Controlled Clinical Trials, 25, 119–142.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., et al. (2006a). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. The American Journal of Psychiatry, 163, 1905–1917.
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., et al. (2006b). Bupropion-sr, sertraline, or venlafaxine-xr after failure of SSRIs for depression. The New England Journal of Medicine, 354, 1231–1242.
Thase, M. E., Friedman, E. S., Biggs, M. M., Wisniewski, S. R., et al. (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. The American Journal of Psychiatry, 164, 739–752.
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., et al. (2006a). Medication augmentation after the failure of SSRIs for depression. The New England Journal of Medicine, 354, 1243–1252.
Trivedi, M. H., Rush, A. J., Wisniewski, S. S., et al. (2006b). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. The American Journal of Psychiatry, 163, 28–40.
Turner, E. H., Matthews, A. M., et al. (2008). Selective publication of antidepressant trials and its influence on apparent efficacy. The New England Journal of Medicine, 358, 252–260.
Vedatam, S. (2006, March 23). Drugs cure depression in half of patients: Doctors have mixed reactions to study findings. The Washington Post, p. A1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boren, J.J., Leventhal, A.M. & Edmund Pigott, H. Just How Effective are Antidepressant Medications? Results of a Major New Study. J Contemp Psychother 39, 93–100 (2009). https://doi.org/10.1007/s10879-008-9095-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10879-008-9095-z